Grand Pharmaceutical GroupCGPHF 86 Days Inventory is 87.99 as of Dec. 2025, which is 22% below its 10-year median of 113.17. GuruFocus rates CGPHF with a GF Score™ of 86/100. The stock has 6 warning signs investors should review. Among 918 Drug Manufacturers companies, Grand Pharmaceutical Group ranks better than 81.81% on this metric.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Grand Pharmaceutical Group's Inventory Turnover for the
six
months ended in Dec. 2025 was 2.07.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Grand Pharmaceutical Group's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.23.
Grand Pharmaceutical Group (OTCPK:CGPHF) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Grand Pharmaceutical Group's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Grand Pharmaceutical Group's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Grand Pharmaceutical Group Days Inventory Related Terms
Grand Pharmaceutical Group Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Grand Pharmaceutical Group's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Grand Pharmaceutical Group Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Grand Pharmaceutical Group's Days Inventory distribution charts can be found below:
* The bar in red indicates where Grand Pharmaceutical Group's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Grand Pharmaceutical Group (CGPHF) has a Days Inventory of 87.99 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Grand Pharmaceutical Group and its competitors. This is 22% below median its historical median of 113.17. Over the past decade, Grand Pharmaceutical Group's Days Inventory has ranged from 94.68 to 139.35. According to the industry distribution chart, Grand Pharmaceutical Group ranks #167 out of 918 companies in the Drug Manufacturers industry, placing it in the top 18.2%.
Is Grand Pharmaceutical Group's Days Inventory too high?
Grand Pharmaceutical Group's current Days Inventory of 87.99 is 22% below median its 10-year median of 113.17. Over the past 10 years, this metric has ranged from a low of 94.68 to a high of 139.35. The Drug Manufacturers industry median Days Inventory is 164.43. Grand Pharmaceutical Group's value of 87.99 is 46.5% below this industry median. Based on the distribution chart, Grand Pharmaceutical Group ranks #167 out of 918 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Grand Pharmaceutical Group has a GF Score™ of 86/100, reflecting its overall financial health beyond just this single metric.
How does Grand Pharmaceutical Group's Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Grand Pharmaceutical Group ranks #167 out of 918 companies for Days Inventory. This places Grand Pharmaceutical Group in the top 18% of its industry — outperforming the majority of peers. The industry median Days Inventory is 164.43. Grand Pharmaceutical Group's value of 87.99 is 46.5% below this benchmark. Historically, Grand Pharmaceutical Group's own Days Inventory has ranged from 94.68 to 139.35 over the past decade. While the company's 10-year median is 113.17 vs. the industry median of 164.43, Grand Pharmaceutical Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.43, based on 918 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Grand Pharmaceutical Group's current Days Inventory of 87.99 is 46.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Grand Pharmaceutical Group and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Grand Pharmaceutical Group's current Days Inventory is 87.99, which is 22% below median its own 10-year median of 113.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Grand Pharmaceutical Group stock overvalued right now?
Grand Pharmaceutical Group (CGPHF) has a current Days Inventory of 87.99. The current Days Inventory is 87.99, which is 22% below median its 10-year median of 113.17 and 46.5% below the Drug Manufacturers industry median of 164.43. Grand Pharmaceutical Group's overall GF Score™ is 86/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Grand Pharmaceutical Group (CGPHF), the current Days Inventory is 87.99 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Grand Pharmaceutical Group Ltd are principally engaged in the manufacture and sales of pharmaceutical technology products, manufacture and sales of bio-technology products as well as manufacture and sales of nuclear medicine anti-tumor diagnosis and treatment and cerebro-cardiovascular precision interventional diagnosis and treatment technology products, in the People's Republic of China. The operation of the group constitutes one single reportable segment. The company has presence in The PRC, America, Europe, Asia other than the PRC and Others. The majority of revenue comes from the PRC. Its brands are breathe, biology, Cardiovascular emergency care, Cardiovascular intervention, ENT, tumor.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CGPHF has been successfully added to your 